Ito H, Hirakawa S
Jpn Circ J. 1984 Apr;48(4):388-404. doi: 10.1253/jcj.48.388.
There have been yet only a few studies on the action of vasodilators on the entire systemic capacitance vessels of the living body. In the present study, we studied the action of the vasodilators on the systemic capacitance vessels by measuring the mean circulatory pressure (MCP), introduced by Guyton, and that on the systemic resistance vessels from total peripheral resistance, in anesthetized open chest dogs. We also studied the venous return curves. Depending on vasodilators and the dosages used, resistance vessels could be dilated, but capacitance vessels could not be dilated. The reverse was never true. It was also found frequently that capacitance vessels could be dilated only when the tone of the capacitance vessels have been previously elevated by norepinephrine. Again, depending on vasodilators and their dosages, the venous return curves were changed in position and/or slope. We constructed a venous return curve by connecting 2 points on the venous return-right atrial pressure (VR-RAP) plane, one, VR-RAP plot, and the other, the point of VR = 0, RAP = MCP. Changes in the venous return curve caused by these vasodilators were classified into three types; (a) a clockwise rotation with a constant MCP, where one sees no change in MCP and decreased resistance to venous return (RVR), so that one may call this RVR-type, (b) a parallel shift of the venous return curve to the left, where one sees no change in RVR but a decreased MCP, so that one may call this MCP-type and (c) a shift to the left plus clockwise rotation, where one sees a decrease in MCP and decrease in RVR, so that this is a mixture of patterns (a) and (b). One may call this the mixed-type. The existence of the response of mixed-type is worth special attention, because, in this type, cardiac output (CO) was increased by the predominant decrease in RVR in spite of a decreased MCP, leading to an important condition that the CO does not necessarily decrease when systemic capacitance vessels were dilated by the vasodilators.
关于血管舒张剂对活体全身容量血管作用的研究尚少。在本研究中,我们通过测量盖顿提出的平均循环压力(MCP)来研究血管舒张剂对全身容量血管的作用,并在麻醉开胸犬中从总外周阻力研究其对全身阻力血管的作用。我们还研究了静脉回流曲线。根据所用血管舒张剂及其剂量,阻力血管可被扩张,但容量血管不能被扩张。反之则从未出现过。还经常发现,只有当容量血管的张力先前已被去甲肾上腺素升高时,容量血管才能被扩张。同样,根据血管舒张剂及其剂量,静脉回流曲线的位置和/或斜率会发生变化。我们通过连接静脉回流-右心房压力(VR-RAP)平面上的两个点来构建静脉回流曲线,一个是VR-RAP图,另一个是VR = 0、RAP = MCP的点。这些血管舒张剂引起的静脉回流曲线变化分为三种类型:(a)在MCP恒定的情况下顺时针旋转,此时MCP无变化,静脉回流阻力(RVR)降低,因此可称为RVR型;(b)静脉回流曲线向左平行移动,此时RVR无变化,但MCP降低,因此可称为MCP型;(c)向左移动并顺时针旋转,此时MCP降低,RVR降低,因此这是(a)和(b)模式的混合。可称为混合型。混合型反应的存在值得特别关注,因为在这种类型中,尽管MCP降低,但由于RVR的显著降低,心输出量(CO)增加,导致一个重要情况,即当血管舒张剂扩张全身容量血管时,CO不一定会降低。